{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:25:26Z","timestamp":1779891926441,"version":"3.53.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002596","name":"American Pharmacists Association Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.japh.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T07:33:31Z","timestamp":1613892811000},"page":"S173-S177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S","title":["Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-4564","authenticated-orcid":false,"given":"Brady","family":"Hecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy R.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-5016","authenticated-orcid":false,"given":"Macary Weck","family":"Marciniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2021.01.001_bib1","author":"Pahlavan"},{"issue":"12","key":"10.1016\/j.japh.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/jid.2015.296","article-title":"Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use","volume":"135","author":"Takeshita","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.japh.2021.01.001_bib5","author":"O\u2019Reilly"},{"issue":"2","key":"10.1016\/j.japh.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacl.2019.01.003","article-title":"Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates","volume":"13","author":"Reynolds","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"issue":"1","key":"10.1016\/j.japh.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.japh.2017.10.011","article-title":"Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals","volume":"58","author":"Zhu","year":"2018","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:30Z","timestamp":1761544110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1544319121000029"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.01.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}